Stay updated on Comparing Bictegravir Combo vs Abacavir Combo in HIV-1 Adult Clinical Trial
Sign up to get notified when there's something new on the Comparing Bictegravir Combo vs Abacavir Combo in HIV-1 Adult Clinical Trial page.

Latest updates to the Comparing Bictegravir Combo vs Abacavir Combo in HIV-1 Adult Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now displays 'No longer looking for participants', indicating recruitment has closed. New help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment label was updated from 'Intervention / Treatment' to 'Intervention/Treatment' with the revision version changed from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check15 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, indicating a newer build of the page’s software/content. This change represents an internal version update rather than any user-facing content modification.SummaryDifference0.0%

- Check22 days agoChange DetectedA new citation by Daar et al. on long-term metabolic changes with Bictegravir/Emtricitabine/Tenofovir Alafenamide versus dolutegravir-containing regimens was added to the Publications section.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a new version of the page metadata.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3, reflecting a technical site release rather than a change to the clinical study content.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Comparing Bictegravir Combo vs Abacavir Combo in HIV-1 Adult Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Bictegravir Combo vs Abacavir Combo in HIV-1 Adult Clinical Trial page.